Calithera biosciences inc.

Major-Pharmaceuticals

CALA


343 Oyster Point Boulevard
South San Francisco , CA 94080

Executive/
Director

Price

  • Last Close
  • $ 0.37
    $ -0.05 -10.98 %
    Feb 1, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 782,291
  • Market Cap Full
  • $ 1.8M
  • Shares Outstanding
  • 4.9M
    Mar 24, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -25.9% 255.4% -24.6% 68.1% -5% -50.7% -43.2% -88.8% - -
Q2 -34.7% 28.6% -21.3% -41.7% 4% -13.6% 550.8% - - -
Q3 -12.4% 6.1% 5% -27.6% 8% 4.3% 19.5% - - -
Q4 - -46.3% -25.5% 96.2% 42.3% -69.5% 10.9% - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -62%-58%157%-52%41%-13%-86%390%-89%0%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.52 0.22 -0.37 -0.61 -0.38 -0.28 -3.6 -
Q2 0.55 0.15 -0.09 -0.58 -0.29 -0.19 1.39 -
Q3 0.44 0.17 -0.52 -0.38 -0.32 -0.15 -2.01 -
Q4 0.45 0.31 -0.51 -0.33 -0.32 -18.69 -3.72 -
A 2 0.9 -1.5 -1.9 -26.2 -31.2 -7.9 0

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 38.8 64.7 73.3 78.7 4.9
Jun 35.8 39.2 70.4 74 97.2 -
Sep 36 53.8 70.6 74.1 4.9 -
Dec 38.1 53.8 70.6 74.9 4.9 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - 10 - - 11
Total Asset Turnover - 0.2 - - 0.2
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 21 - 91 31 28.5
Equity multiplier - - - - -